Form 13-F position report

INVO BIOSCIENCE INC

Reported by MORGAN STANLEY

Company profile Manager portfolio Source filing
INVO CUSIP 44984F302 Manager CIK 0000895421
Latest reported change

Reported 0 shares, down 843 (100.0%) from the prior quarter.

Reported value -100.0%; share count -100.0% vs. the prior quarter.

Reduced
% of reported 13F value 0 This manager · Q3 2023
Shares 0 Quarter-end amount reported
Reported value $0 Fair value at quarter end
Consecutive quarters held 4 Through Q3 2023

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Manager history

Quarterly position history

How this manager's reported quarter-end position changed over time.

8 quarters
Quarter Activity Shares Change % of reported 13F Reported value Filed
Q3 2023 Reduced 0 -843 (-100.0%) 0 $0 2023-11-15
Q2 2023 Unchanged 843 0 (0.0%) < 0.01% $169 2023-08-14
Q1 2023 Unchanged 843 0 (0.0%) < 0.01% $539 2023-05-15
Q4 2022 New 843 +843 (0.0%) < 0.01% $357 2023-02-14
Q2 2022 Reduced 0 -848 (-100.0%) 0 $0 2022-08-15
Q1 2022 Added 848 +5 (0.6%) < 0.01% $2,000 2022-05-13
Q4 2021 Unchanged 843 0 (0.0%) < 0.01% $3,000 2022-02-14
Q3 2021 Unchanged 843 0 (0.0%) < 0.01% $3,000 2021-11-15
Five years are shown. A free account unlocks the complete reported history. Unlock full history
Institutional context

Who else reported the position

19 managers reported INVO BIOSCIENCE INC for Q3 2023.

Manager Activity Shares Change % of reported 13F Reported value Tenure
AWM Investment Company Inc Reduced 32,000 -591,860 < 0.01% $25,286 12 qtrs
TWO SIGMA SECURITIES LLC Reduced 0 -28,551 0 $0 2 qtrs
Tower Research Capital LLC TRC Reduced 0 -9,713 0 $0 11 qtrs
RENAISSANCE TECHNOLOGIES LLC Reduced 0 -20,200 0 $0 2 qtrs
UBS Group AG Reduced 0 -700 0 $0 12 qtrs
CONCOURSE FINANCIAL GROUP SECURITIES INC Unchanged 0 0 0 $0 12 qtrs
MORGAN STANLEY This report Reduced 0 -843 0 $0 4 qtrs
Gleason Group Inc Reduced 0 -62 0 $0 12 qtrs
STATE STREET CORPORATION Reduced 0 -23,781 0 $0 10 qtrs
ROYAL BANK OF CANADA Reduced 0 -10,773 0 $0 12 qtrs
A free account expands this comparison to 25 managers. Create free account
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2023
Filed
November 15, 2023
Filing type
13F-HR
Position type
COM

Voting authority reported

No voting-authority amounts were reported for this position. Voting authority is not required for reported call options.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.